Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Canopy Growth Corporation
  6. Summary
    WEED   CA1380351009

CANOPY GROWTH CORPORATION

(WEED)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
14.83(c) 14.72(c) 15.04(c) 15.17(c) 14.81(c) Last
1 886 689 1 984 064 1 744 308 319 390 1 307 271 Volume
-3.76% -0.74% +2.17% +0.86% -2.37% Change
More quotes
Estimated financial data (e)
Sales 2022 584 M 458 M 458 M
Net income 2022 156 M 123 M 123 M
Net Debt 2022 311 M 244 M 244 M
P/E ratio 2022 37,7x
Yield 2022 -
Sales 2023 760 M 596 M 596 M
Net income 2023 -325 M -255 M -255 M
Net Debt 2023 581 M 455 M 455 M
P/E ratio 2023 -18,3x
Yield 2023 -
Capitalization 5 830 M 4 559 M 4 572 M
EV / Sales 2022 10,5x
EV / Sales 2023 8,43x
Nbr of Employees 3 259
Free-Float 63,8%
More Financials
Company
Canopy Growth Corporation is a Canada-based diversified cannabis, hemp, and cannabis device company, which offers a diverse range of cannabis and hemp-based products and other consumer products for both recreational and medical purposes under a portfolio of distinct brands in Canada. The Company operates through two segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the... 
Sector
Pharmaceuticals
Calendar
02/09Earnings Release
More about the company
Ratings of Canopy Growth Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about CANOPY GROWTH CORPORATION
11/26SpeakEasy Cannabis Club Warns of Potential Delay in Filing Annual Results
MT
11/26Eve & Co.'s Q3 Loss Narrows YoY, Says 9-Month Revenue Already Above FY2020 Levels
MT
11/26Flora Growth to Form FloVaria Joint Venture With Canada's Avaria Health & Beauty
MT
11/26Lifeist Wellness Sells Cannabis-Related IP to Payments Startup Owned by Its Former CTO
MT
11/25Greenrise Global Brands Welcomes Germany's Legalization of Cannabis for Adults
MT
11/25Medical Cannabis Company Equinox International Plans AIM IPO in London
MT
11/24'OUT OF CONTROL' : Small Australian firm wrongly named as Taliban hashish partner
RE
11/24CANOPY GROWTH : Announces Changes to Executive Management Team - Form 8-K
PU
11/24CANOPY GROWTH CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, ..
AQ
11/24Pathway Health Reports Q3 Net Loss of $0.02 Per Share
MT
11/24Emyria Receives $840,000 R&D Tax Rebate
MT
11/23Toronto stock index snaps four days of declines as energy shares rise
RE
11/23Toronto stock index snaps four days of declines as energy shares rise
RE
11/23Organigram Up Over 11% as Fiscal Q4 Revenue Unexpectedly Rises YoY; Net Loss Narrows
MT
11/23MediPharm Expands CBN Portfolio with 2 New Products; Down 2.1%
MT
More news
News in other languages on CANOPY GROWTH CORPORATION
11/28UMFRAGE : Cannabis-Legalisierung spaltet die Bevölkerung
11/26WDH : Polizeigewerkschaft kritisiert geplante Cannabis-Legalisierung
11/25PRESSESTIMME : 'Schwäbische Zeitung' zu Cannabis
11/25BOURSE : en l'absence de Wall Street, l'Europe avance
11/25MÄRKTE EUROPA/Versorger schalten mit Ampelkoalition in Berlin auf Grün
More news
Analyst Recommendations on CANOPY GROWTH CORPORATION
More recommendations
Chart CANOPY GROWTH CORPORATION
Duration : Period :
Canopy Growth Corporation Technical Analysis Chart | WEED | CA1380351009 | MarketScreener
Technical analysis trends CANOPY GROWTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Last Close Price 14,81 CAD
Average target price 17,88 CAD
Spread / Average Target 20,7%
EPS Revisions
Managers and Directors
Bruce Linton Chairman & Co-Chief Executive Officer
David Eric Klein Chief Executive Officer & Non-Independent Director
Rade Kovacevic President & Chief Product Officer
Mike Lee Chief Financial Officer & Executive Vice President
Judy A. Schmeling Chairman